Estrella Immunopharma, Inc.
ESLA • NASDAQ
Estrella Immunopharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Cheng Liu, with a market cap of $44.8M.
CEOCheng Liu
Next Earnings
Upcoming earnings announcement for Estrella Immunopharma, Inc.
Date
Tuesday, May 26, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.12
Earnings History
Past 7 earnings reports for Estrella Immunopharma, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Q4 2025 | -$0.01Est: -$0.12 | +91.7% | - | — | — |
| Nov 12, 2025 | Q3 2025 | -$0.13 | — | - | — |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.15Est: -$0.11 | -36.4% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.06 | — | - | — | 10-Q |
| Sep 27, 2024 | Q4 2024 | -$0.13 | — | - | — | 10-K/A |
| May 15, 2024 | Q3 2024 | -$0.01 | — | - | — | 10-Q |
| Feb 14, 2024 | Q2 2024 | -$0.03 | — | - | — | 10-Q |